Research Progress on the Mechanisms of Immunomodulatory Effects of Plant Polysaccharides (Part I)
Plant polysaccharides, abbreviated as PPS, are compounds composed of many identical or different monosaccharides linked by α- or β-glycosidic bonds.
September 8, 2025
by Xiaonisha
Advances in the Research of Targeting B Cells for the Treatment of Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is a chronic, systemic autoimmune disease. The direct cause of SLE pathogenesis lies in the immune imbalance resulting from excessive B-cell activation.
July 25, 2025
by Xiaonisha
Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots
Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow bioreactor: the Bioprocessor.
January 15, 2025
by PRNewswire
Research and Development Status and Progress of Antibody Technology (Part Ⅱ)
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
July 18, 2024
by Xiaomichong
Research and Development Status and Progress of Antibody Technology (Part I)
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
July 18, 2024
by Xiaomichong
How is the progress of China’s domestically produced PD-(L)1 “going global”?
Recently, Coherus BioSciences announced that the FDA has approved the launch of PD-1 antibody toripalimab (marketed jointly by Junshi Biosciences and Coherus) for use in combination with gemcitabine/cisplatin as a first-line treatment for advanced recurre
November 23, 2023
by Yefenghong/PharmaSources
A comprehensive review of the currently marketed ADC drugs: the industry maintains high prosperity
Antibody-drug conjugates (ADCs) are a class of drugs composed of antibodies targeting tumor antigens and a variable number of small molecule toxins linked through connectors.
November 7, 2023
by WND
Research Progress on the Application of Biologics in Childhood Asthma.
Asthma is a heterogeneous, complex chronic disease. Children with severe asthma often experience acute exacerbations, leading to impaired lung function and poor quality of life.
October 30, 2023
by Xiaomichong
Pharmaceutical Business Progress in China and Worldwide (March)
Progress in Pharmaceutical Business at Home and Abroad (March)
May 12, 2023
by PharmaSources
Weekly Pharma News Review | PharmaSources.com (March 21 to 25)
Henlius PD-1 was launched this week, becoming the 7th China-made PD-1 monoclonal antibody and the 13th PD-1/PD-L1 monoclonal antibody that was marketed in China.
March 30, 2022
by PharmaSources/Caicai
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing...
February 18, 2022
by PharmaSources.com
Novel antibody helps block COVID transmission in cells, finds study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells.
February 15, 2022
by ExpressPharma